Maternal Tachycardia in Second Trimester: Evaluation and Management
Maternal tachycardia in the second trimester is most commonly physiological (heart rate increases by 10-20 bpm above baseline, peaking at 32 weeks), but persistent tachycardia >100 bpm at rest or symptomatic palpitations warrant systematic evaluation to exclude pathological arrhythmias that can compromise maternal and fetal outcomes.
Understanding Normal Physiological Changes
During the second trimester, significant cardiovascular adaptations occur that commonly cause tachycardia 1:
- Heart rate increases starting at 20 weeks, reaching maximum at 32 weeks (typically 10-20 bpm above baseline)
- Cardiac output increases 30-50% above non-pregnant values
- Blood pressure typically falls, with diastolic BP dropping ~10 mmHg in the second trimester
- Plasma volume peaks at 40% above baseline by 24 weeks
These changes are normal adaptations to meet increased metabolic demands and do not require treatment unless symptomatic.
When to Investigate Further
Always pursue diagnostic workup if 2:
- Persistent tachycardia >100 bpm at rest, regardless of symptoms
- Symptomatic palpitations (dizziness, chest pain, dyspnea, syncope)
- Irregular rhythm on examination
- History of structural heart disease or prior arrhythmias
- Family history of sudden cardiac death or inherited arrhythmias
Diagnostic Approach
Essential Initial Workup 2, 3:
12-lead ECG - to identify:
- Baseline rhythm and rate
- Pre-excitation patterns (WPW)
- QT interval abnormalities
- Structural disease markers
Laboratory tests:
- Thyroid function (hyperthyroidism common cause)
- Complete blood count (anemia)
- Electrolytes (hypokalemia, hypomagnesemia)
- Renal function
Echocardiography - if:
- Abnormal ECG findings
- Suspected structural heart disease
- Persistent unexplained tachycardia
- Hemodynamic instability
Ambulatory monitoring (Holter/event recorder):
- This is the key diagnostic test - captures rhythm during symptomatic episodes 2
- Essential for documenting paroxysmal arrhythmias
Management Based on Etiology
Physiological Sinus Tachycardia
If workup is negative and patient has simple sinus tachycardia 1:
- Reassurance is the primary intervention
- Address contributing factors: anxiety, dehydration, anemia, hyperthyroidism
- No antiarrhythmic therapy needed
- Avoid unnecessary medications
Pathological Supraventricular Tachycardia (SVT)
For acute symptomatic SVT 1, 4:
If hemodynamically unstable:
- Immediate synchronized electrical cardioversion (safe at all stages of pregnancy) 1, 5
- Do not delay for fetal monitoring
If hemodynamically stable with regular narrow-complex tachycardia:
- First-line: Vagal maneuvers (Valsalva, carotid massage) 1
- Second-line: IV adenosine (6 mg → 12 mg → 12 mg) 1, 4
- Safe in pregnancy, not teratogenic
- Brief, self-limited side effects
- Third-line: IV beta-blockers (metoprolol or propranolol) 1
Long-term Prophylaxis for Recurrent SVT
For symptomatic recurrent episodes 1, 4:
First-line agents:
Second-line agents (if first-line fails):
- Sotalol or flecainide 1, 4
- Note: Flecainide/propafenone must be combined with AV nodal blocking agent to prevent 1:1 atrial flutter conduction 4
Important caveat: Beta-blockers are not teratogenic but are associated with fetal growth restriction - use lowest effective dose 5, 6.
Atrial Fibrillation/Flutter
For new-onset AF/flutter in second trimester 4:
If duration <48 hours:
- Cardioversion (electrical or pharmacological) can proceed
- Minimum 4 weeks post-cardioversion anticoagulation required
If duration >48 hours or unknown:
- Anticoagulate for 3 weeks before elective cardioversion, OR
- Perform TEE to exclude thrombus, then cardiovert
- Minimum 4 weeks post-cardioversion anticoagulation
Anticoagulation considerations:
- Required if structural heart disease present or elevated thromboembolic risk
- Use LMWH or unfractionated heparin (warfarin acceptable in second trimester but avoid in first and third)
Catheter Ablation During Pregnancy
Consider catheter ablation if 1, 7:
- Drug-refractory symptomatic tachycardia
- Hemodynamic instability despite medical therapy
- Patient preference to avoid long-term medications
- Postpone to second trimester if possible (after 12 weeks)
- Use zero-fluoroscopy techniques with 3D electroanatomic mapping and intracardiac echocardiography
- Perform at experienced centers with appropriate shielding
- Can be safely performed at 28-29 weeks if needed 7
Critical Pitfalls to Avoid
- Do not dismiss persistent tachycardia as "just pregnancy" - always investigate 2
- Do not delay cardioversion in unstable patients - electrical cardioversion is safe throughout pregnancy 1, 5
- Do not use amiodarone except as absolute last resort - significant fetal thyroid and developmental risks 1
- Do not use verapamil as first-line - only consider if other agents fail 1
- Do not forget anticoagulation in AF/flutter with structural heart disease 4
- Do not use flecainide/propafenone without AV nodal blockade - risk of 1:1 flutter conduction 4
Multidisciplinary Care Requirements
All pregnant patients with pathological arrhythmias require 2, 3:
- Cardiology consultation (preferably electrophysiologist)
- High-risk obstetrics involvement
- Obstetric anesthesia planning for delivery
- Coordinated delivery planning at tertiary center